Form 4 holding
Director
Nabriva Therapeutics plc
- Security class
- Ordinary Shares
- Shares / value
- 36,523
- Estimated value
- $54,785
- Report date
- 02 Aug 2022
- Price
- $1.50
- Ownership
- Direct
Colin Broom MD
Insider Reports History
- Reporting-owner location
- West Chester, PA
- Latest reporting-owner signature
-
/s/ J. Christopher Naftzger, by power of attorney
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Colin Broom MD
Insider Reports Filed by Colin Broom MD
4
Nabriva Therapeutics plc
- Report period
- 02 Aug 2022
- Transactions
- 1
- Transaction value
- -$1,015
- Accepted by SEC
- 04 Aug 2022, 18:22
- Role
- Director
- Next action
- Open filing details
4
Nabriva Therapeutics plc
- Report period
- 02 Aug 2021
- Transactions
- 1
- Transaction value
- -$637
- Accepted by SEC
- 04 Aug 2021, 21:06
- Role
- Director
- Next action
- Open filing details
4
Nabriva Therapeutics plc
- Report period
- 28 Jul 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 30 Jul 2021, 20:22
- Role
- Director
- Next action
- Open filing details